Full Text
The Full Text of this article is available as a PDF (22.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Allen K. W., Humphreys H., Sims-Williams R. F. Sterilization of instruments in general practice: what does it entail? Public Health. 1997 Mar;111(2):115–117. doi: 10.1016/s0033-3506(97)90012-3. [DOI] [PubMed] [Google Scholar]
- Cade J., O'Connell S. Management of weight problems and obesity: knowledge, attitudes and current practice of general practitioners. Br J Gen Pract. 1991 Apr;41(345):147–150. [PMC free article] [PubMed] [Google Scholar]
- Drent M. L., Larsson I., William-Olsson T., Quaade F., Czubayko F., von Bergmann K., Strobel W., Sjöström L., van der Veen E. A. Orlistat (Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study. Int J Obes Relat Metab Disord. 1995 Apr;19(4):221–226. [PubMed] [Google Scholar]
- Little P. GP documentation of obesity: what does it achieve? Br J Gen Pract. 1998 Jan;48(426):890–894. [PMC free article] [PubMed] [Google Scholar]
- Ridgway G. L., Hodges C. J., Kreuzer M. H. Implications of European directive on medical devices. Lancet. 1998 Jun 20;351(9119):1831–1832. doi: 10.1016/s0140-6736(05)78802-4. [DOI] [PubMed] [Google Scholar]
- Sjöström L., Rissanen A., Andersen T., Boldrin M., Golay A., Koppeschaar H. P., Krempf M. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet. 1998 Jul 18;352(9123):167–172. doi: 10.1016/s0140-6736(97)11509-4. [DOI] [PubMed] [Google Scholar]
- Traeden U. I., Holm L., Sandström B., Andersen P. K., Jarden M. Effectiveness of a dietary intervention strategy in general practice: effects on blood lipids, health and well-being. Public Health Nutr. 1998 Dec;1(4):273–281. doi: 10.1079/phn19980044. [DOI] [PubMed] [Google Scholar]